MedPath

郑州卓峰制药有限公司

Ownership
-
Established
2008-10-27
Employees
-
Market Cap
-
Website
http://www.zzzfzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

57

NMPA:57

Drug Approvals

Diquafosol Sodium Eye Drops

Product Name
地夸磷索钠滴眼液
Approval Number
国药准字H20254146
Approval Date
May 13, 2025
NMPA

Gatifloxacin Eye Drops

Product Name
加替沙星滴眼液
Approval Number
国药准字H20080653
Approval Date
Mar 1, 2023
NMPA

甘桔清咽颗粒

Approval Number
国药准字Z20100043
Approval Date
Mar 1, 2023
NMPA

Dexamethasone Sodium Phosphate Eye Drops

Product Name
地塞米松磷酸钠滴眼液
Approval Number
国药准字H19983026
Approval Date
Mar 15, 2021
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H41025291
Approval Date
Sep 4, 2020
NMPA

Lincomycin Hydrochlorde Injection

Product Name
盐酸林可霉素注射液
Approval Number
国药准字H41025317
Approval Date
Sep 4, 2020
NMPA

Vitamin B12 Injection

Product Name
维生素B12注射液
Approval Number
国药准字H41025323
Approval Date
Sep 4, 2020
NMPA

Vitamin B6 Injection

Product Name
维生素B6注射液
Approval Number
国药准字H41025324
Approval Date
Sep 4, 2020
NMPA

Vitamin B6 Injection

Product Name
维生素B6注射液
Approval Number
国药准字H41025325
Approval Date
Sep 4, 2020
NMPA

Potassium Chloride Injection

Product Name
氯化钾注射液
Approval Number
国药准字H41025290
Approval Date
Sep 4, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.